Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Back to Journals ImmunoTargets and Therapy Volume 15 Recent Advances in Vitiligo Treatment Authors Qiu Y , Su X, Chen J, Jiang S, Tang X, He Y , Liu F Received 29 October 2025 Accepted for publication 1 February 2026 Published 11 February 2026 Volume 2026:15 577653 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Sarah Wheeler Ye Qiu, Xiangxi Su, Jingru Chen, Shaojing Jiang, Xinrui Tang, Yurong He, Fang Liu Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Peoples Republic of China Correspondence: Fang Liu, Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Peoples Republic of China, Email [email protected] Purpose: This review systematically summarizes breakthrough advances in vitiligo treatment from 2020 to 2025 to provide the latest evidence-based insights for clinical practice
GLP-1 plays a key role in regulating blood sugar, appetite, and insulin secretion
Glutathione HERO master melanin inhibitor What changes, one wipe at a time Realistic milestones based on twice-daily use
10.2337/dc19-S009 73
Antioxidants neutralise harmful free radicals that can harm cells
A clean safety profile across TRIUMPH-1 and TRIUMPH-3 would help Lilly file faster and would discourage the FDA from requesting additional studies
